Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
American Journal of Clinical Pathology|December 14, 2020
Bronchiolar Adenoma/Pulmonary Ciliated Muconodular Papillary TumorHemlata Shirsat, Fang Zhou, Jason C Chang, et al.
The Journal of Molecular Diagnostics : JMD|December 22, 2018
Next-Generation Sequencing-Based Assessment of JAK2, PD-L1, and PD-L2 Copy Number Alterations at 9p24.1 in Breast Cancer: Potential Implications for Clinical ManagementSounak Gupta, Chad M Vanderbilt, Paolo Cotzia, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 14, 2023
Neurofibromatosis Type 2-Yes-Associated Protein and Transcriptional Coactivator With PDZ-Binding Motif Dual Immunohistochemistry Is a Reliable Marker for the Detection of Neurofibromatosis Type 2 Alterations in Diffuse Pleural MesotheliomaYan Li, Soo-Ryum Yang, Ying-Bei Chen, et al.
The American Journal of Surgical Pathology|January 20, 2026
Primary Pulmonary Ameloblastoma: First Case Series With Clinicopathologic and Genomic AnalysisJason C Chang, Omid Savari, Najd Alshamlan, et al.
The American Journal of Surgical Pathology|May 31, 2018
Bronchiolar Adenoma: Expansion of the Concept of Ciliated Muconodular Papillary Tumors With Proposal for Revised Terminology Based on Morphologic, Immunophenotypic, and Genomic Analysis of 25 CasesJason C Chang, Joseph Montecalvo, Laetitia Borsu, et al.
Cancer Discovery|November 6, 2023
Alveolar Differentiation Drives Resistance to KRAS Inhibition in Lung AdenocarcinomaZhuxuan Li, Xueqian Zhuang, Chun-Hao Pan, et al.
JTO Clinical and Research Reports|July 21, 2025
A Phase II Study of Cabozantinib in Patients With MET-Altered Lung CancersGuilherme Harada, Fernando C Santini, Clare J Wilhelm, et al.
Biorxiv : the Preprint Server for Biology|October 9, 2023
Alveolar differentiation drives resistance to KRAS inhibition in lung adenocarcinomaZhuxuan Li, Xueqian Zhuang, Chun-Hao Pan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 27, 2022
POU2F3 in SCLC: Clinicopathologic and Genomic Analysis With a Focus on Its Diagnostic Utility in Neuroendocrine-Low SCLCMarina K Baine, Christopher A Febres-Aldana, Jason C Chang, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 30, 2019
Stage IV lung carcinoids: spectrum and evolution of proliferation rate, focusing on variants with elevated proliferation indicesNatasha Rekhtman, Patrice Desmeules, Anna M Litvak, et al.
Pageof 5